Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

VistaGen Therapeutics Inc VSTA

Sector: Healthcare | Sub-Sector: Biotechnology

VistaGen Therapeutics Inc is a stem cell company. The Company focused on drug rescue and regenerative medicine.
Price: $11.75 | Change: +$2.75 | %Change: +30.56%
Volume: 100 | Day High/Low: 11.75/11.75 | 52 Week High/Low: 15.00/9.00
View modes: 
0 stars

VistaGen Therapeutics, Inc. (VSTA) Receives Notice of Allowa

VistaGen Therapeutics, Inc. (VSTA) Receives Notice of Allowance for Stem Cell Technology Today before the opening bell, VistaGen Therapeutics announced its reception of a Notice of Allowance from the...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Provides Reverse Stock Sp

VistaGen Therapeutics, Inc. (VSTA) Provides Reverse Stock Split FAQs Last week, VistaGen Therapeutics implemented a 1-for-20 reverse split of its common stock. As a result, the number of shares of...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Announces New Agreement

VistaGen Therapeutics, Inc. (VSTA) Announces New Agreement with Largest Shareholder In an 8-K filed with the SEC today, VistaGen Therapeutics announced that Platinum Long Term Growth VII, LLC, the...read more
0 stars

Millions in Grant Funding Provide Foundation of Opportunity

Millions in Grant Funding Provide Foundation of Opportunity for VistaGen Therapeutics, Inc. (VSTA) The National Institute of Health aims to supports biomedical science and behavioral research through...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) at Forefront of Stem Cel

VistaGen Therapeutics, Inc. (VSTA) at Forefront of Stem Cell Technology for Drug Rescue, Regenerative Medicine, Small Molecule Drugs VistaGen Therapeutics stands at the forefront today of the rapidly...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Drug Rescue Model Resusc

VistaGen Therapeutics, Inc. (VSTA) Drug Rescue Model Resuscitates Failed Drug Candidates VistaGen Therapeutics is focused on drug rescue and regenerative medicine, applying its pluripotent stem cell...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Employs a Unique Drug Re

VistaGen Therapeutics, Inc. (VSTA) Employs a Unique Drug Rescue Model VistaGen Therapeutics is a biotechnology company mainly focusing on human pluripotent stem cell (hPSC) technology for drug rescue...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Expands IP Portfolio, Aw

VistaGen Therapeutics, Inc. (VSTA) Expands IP Portfolio, Awarded Canadian Patent Coverage VistaGen Therapeutics, a biotech company using proprietary pluripotent stem cell technology for drug rescue...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Stands to Reverse Tremend

VistaGen Therapeutics, Inc. (VSTA) Stands to Reverse Tremendous Costs of Drug Failure with Pluripotent Stem Cell Technology For 16 years, California-based VistaGen Therapeutics has worked with key...read more
0 stars

VistaGen, Inc. (VSTA) Aims to Breathe Life into Shelved, Hig

VistaGen, Inc. (VSTA) Aims to Breathe Life into Shelved, High Potential Drug Candidates and Revitalize Drug Development VistaGen Therapeutics is a stem cell company which centers its attention on...read more
0 stars

VistaGen, Inc. (VSTA) Aims to Breathe Life into Shelved, Hig

VistaGen, Inc. (VSTA) Aims to Breathe Life into Shelved, High Potential Drug Candidates and Revitalize Drug Development VistaGen is a biotech company applying pluripotent stem cell technology for...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Joins HESI Cardiac Safety

VistaGen Therapeutics, Inc. (VSTA) Joins HESI Cardiac Safety Committee, Sees Collaborative Benefits VistaGen Therapeutics, a biotechnology company applying pluripotent stem cell technology for drug...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Human Pluripotent Stem Ce

VistaGen Therapeutics, Inc. (VSTA) Human Pluripotent Stem Cell-Based Bioassay Technology Stands to Revolutionize $51B+ Drug R&D Space VistaGen Therapeutics stands at the forefront of the biotech...read more
0 stars

National Institute of Health’s Focus on Drug Rescue to Benef

National Institute of Health’s Focus on Drug Rescue to Benefit VistaGen Therapeutics (VSTA) VistaGen Therapeutics is a 16-year-old biotechnology company that uses human pluripotent stem cell (hPSC...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Receives Notice of Allowa

VistaGen Therapeutics, Inc. (VSTA) Receives Notice of Allowance for U.S. Patent Expanding Stem Cell Technology Platform for Drug Rescue and Regenerative Medicine Today, VistaGen Therapeutics...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Stem Cell Expertise Bring

VistaGen Therapeutics, Inc. (VSTA) Stem Cell Expertise Brings New Life to Discarded Drug Candidates VistaGen Therapeutics is a San Francisco-based biotechnology company that focuses on human stem...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Commercial Drug Rescue Po

VistaGen Therapeutics, Inc. (VSTA) Commercial Drug Rescue Potential Underwritten by Stem Cell Bioassay’s Cardiac Drug Safety Benchmarking VistaGen’s human pluripotent stem cell (hPSC) based approach...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Joins the Cardiac Researc

VistaGen Therapeutics, Inc. (VSTA) Joins the Cardiac Research Safety Consortium Today, VistaGen Therapeutics announced its membership in the Cardiac Research Safety Consortium, a public-private...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Strategy Offers Foresight

VistaGen Therapeutics, Inc. (VSTA) Strategy Offers Foresight in Drug Candidate Approval Process VistaGen Therapeutics believes the U.S. pharmaceutical industry is facing a drug discovery and...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Impressive in Predicting

VistaGen Therapeutics, Inc. (VSTA) Impressive in Predicting Test Outcomes of Vital Drug Candidates VistaGen Therapeutics is keenly aware that despite decades of well-intentioned awareness and...read more